Suppr超能文献

ASFA COVID-19 工作组的报告:在 SARS-CoV-2 冠状病毒病(COVID-19)大流行期间对血浆分离术程序的考虑和优先级排序。

The report from ASFA COVID-19 taskforce: Considerations and prioritization on apheresis procedures during the SARS-CoV-2 coronavirus disease (COVID-19) pandemic.

机构信息

Division of Transfusion Medicine, Department of Pathology, University of Michigan, Ann Arbor, Michigan, USA.

Division of Transfusion Medicine, Department of Laboratory Medicine, University of California San Francisco School of Medicine, San Francisco, California, USA.

出版信息

J Clin Apher. 2021 Dec;36(6):878-881. doi: 10.1002/jca.21939. Epub 2021 Sep 12.

Abstract

Since vaccination for SARS-CoV-2 coronavirus started, the trajectory of patient numbers infected with the virus has improved once; however, variants of SARS-CoV-2 have emerged and more people have been infected; therefore, pandemic status is still far from resolution. Government and social efforts to prevent coronavirus infection continue in most states in the US and globally even after the Centers for Disease Control and Prevention declared some restriction relief for fully vaccinated people in March 2021. Healthcare institutions and various professional organizations have developed guidelines or policies to prevent the spread of these coronaviruses in the setting of apheresis. In this report, the issues that apheresis services may encounter under the current COVID-19 (SARS-CoV-2 coronavirus disease) pandemic will be discussed with potential strategies that can be adapted for efficient and optimum use of apheresis resources.

摘要

自开始接种 SARS-CoV-2 冠状病毒疫苗以来,感染该病毒的患者数量的轨迹有所改善;然而,SARS-CoV-2 的变体已经出现,更多的人被感染;因此,大流行状况仍远未得到解决。即使美国疾病控制与预防中心在 2021 年 3 月宣布对完全接种疫苗的人放宽一些限制,美国和全球大多数州的政府和社会仍在继续努力预防冠状病毒感染。医疗机构和各种专业组织制定了指南或政策,以防止在单采环境中这些冠状病毒的传播。在本报告中,将讨论单采服务在当前 COVID-19(SARS-CoV-2 冠状病毒病)大流行下可能遇到的问题,并提出可适应的潜在策略,以有效和最佳地利用单采资源。

相似文献

2
3
Apheresis physician well-being during the COVID-19 pandemic: Results of a survey.
Transfusion. 2021 May;61(5):1542-1550. doi: 10.1111/trf.16340. Epub 2021 Mar 9.
4
The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.
J Biol Regul Homeost Agents. 2021 Jan-Feb;35(1):1-4. doi: 10.23812/21-3-E.
7
A Reminder of Skin Cancer During the COVID-19 Pandemic.
Acta Dermatovenerol Croat. 2021 Apr;291(1):58.
8
Nurses perspective of apheresis in SARS-CoV-2 infected patients.
Transfus Apher Sci. 2023 Apr;62(2):103670. doi: 10.1016/j.transci.2023.103670. Epub 2023 Feb 24.
9
The ABC's of disaster management: Managing apheresis operations during the SARS-CoV-2 pandemic.
J Clin Apher. 2020 Aug;35(4):243-245. doi: 10.1002/jca.21803. Epub 2020 Jun 30.
10

本文引用的文献

1
Plasma Exchange to Rescue Patients with Autoantibodies Against Type I Interferons and Life-Threatening COVID-19 Pneumonia.
J Clin Immunol. 2021 Apr;41(3):536-544. doi: 10.1007/s10875-021-00994-9. Epub 2021 Feb 22.
4
Plasma exchange in the treatment of complex COVID-19-related critical illness: controversies and perspectives.
Int J Antimicrob Agents. 2021 Feb;57(2):106273. doi: 10.1016/j.ijantimicag.2020.106273. Epub 2020 Dec 25.
5
Plasmapheresis reduces cytokine and immune cell levels in COVID-19 patients with acute respiratory distress syndrome (ARDS).
Pulmonology. 2021 Nov-Dec;27(6):486-492. doi: 10.1016/j.pulmoe.2020.10.017. Epub 2020 Dec 4.
6
Therapeutic plasma exchange for COVID-19-associated hyperviscosity.
Transfusion. 2021 Apr;61(4):1029-1034. doi: 10.1111/trf.16218. Epub 2020 Dec 9.
7
Peripheral neuropathy in severe COVID-19 resolved with therapeutic plasma exchange.
Clin Case Rep. 2020 Oct 7;8(12):3234-3239. doi: 10.1002/ccr3.3397. eCollection 2020 Dec.
10
Therapeutic plasma exchange in adult critically ill patients with life-threatening SARS-CoV-2 disease: A pilot study.
J Crit Care. 2020 Dec;60:328-333. doi: 10.1016/j.jcrc.2020.07.001. Epub 2020 Jul 31.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验